{"id":889,"date":"2025-04-19T06:00:12","date_gmt":"2025-04-19T06:00:12","guid":{"rendered":"https:\/\/perfusfind.com\/ic\/?p=889"},"modified":"2025-04-19T01:57:59","modified_gmt":"2025-04-19T01:57:59","slug":"monitoring-patients-with-acute-respiratory-failure-during-non-invasive-respiratory-support-to-minimize-harm-and-identify-treatment-failure","status":"publish","type":"post","link":"https:\/\/perfusfind.com\/ic\/index.php\/2025\/04\/19\/monitoring-patients-with-acute-respiratory-failure-during-non-invasive-respiratory-support-to-minimize-harm-and-identify-treatment-failure\/","title":{"rendered":"Monitoring patients with acute respiratory failure during non-invasive respiratory support to minimize harm and identify treatment failure"},"content":{"rendered":"
\n

Summary of “Monitoring patients with acute respiratory failure during non-invasive respiratory support to minimize harm and identify treatment failure”<\/strong><\/p>\n<\/blockquote>\n

Abstract:<\/strong> This review article emphasizes the importance of monitoring patients with acute respiratory failure (ARF) who are undergoing non-invasive respiratory support (NRS), such as high-flow nasal oxygen (HFNO), continuous positive airway pressure (CPAP), or non-invasive ventilation (NIV). Although NRS can prevent the need for intubation and invasive mechanical ventilation (IMV), delayed recognition of treatment failure can lead to worsened outcomes due to factors like respiratory muscle fatigue, cardiovascular collapse, and patient self-inflicted lung injury (P-SILI). The authors highlight the physiological principles behind NRS, indications and contraindications, and various monitoring tools and parameters\u2014ranging from dyspnea assessment and respiratory rate to gas exchange and esophageal pressure measurement\u2014to guide timely intervention and minimize harm.<\/p>\n

\n
\n
<\/div>\n<\/div>\n

Key Points:<\/strong><\/p>\n

    \n
  1. \n

    Role of NRS in ARF Management:<\/strong> Non-invasive respiratory support helps alleviate the burden on respiratory muscles, enhances oxygenation, and may prevent intubation, especially in patients with acute hypoxemic respiratory failure (AHRF), cardiogenic pulmonary edema, COPD exacerbations, and chest trauma.<\/p>\n<\/li>\n

  2. \n

    Dangers of Prolonged NRS in Non-responders:<\/strong> Extended use of NRS in patients with high respiratory effort can lead to muscle fatigue, hemodynamic instability, and worse outcomes due to delayed transition to IMV.<\/p>\n<\/li>\n

  3. \n

    Physiological Benefits of HFNO, CPAP, and NIV:<\/strong> HFNO reduces inspiratory resistance and dead space while providing low levels of PEEP; CPAP and NIV add airway pressure support, reduce breathing work, and improve gas exchange\u2014especially when delivered via helmet interfaces.<\/p>\n<\/li>\n

  4. \n

    Indications and Interface Selection:<\/strong> HFNO is typically first-line for AHRF with PaO\u2082\/FiO\u2082 >150 mmHg. Helmet CPAP\/NIV is preferable in more severe AHRF, and facemasks or full-face interfaces may be used depending on patient tolerance and clinical context.<\/p>\n<\/li>\n

  5. \n

    Predictors of NRS Failure:<\/strong> High disease severity, immunosuppression, vasopressor requirement, low PaO\u2082\/FiO\u2082 ratios, and high SAPS II or SOFA scores are associated with poor NRS response and increased likelihood of intubation.<\/p>\n<\/li>\n

  6. \n

    Monitoring Tools and Indices:<\/strong> Key parameters include respiratory rate, tidal volume, minute ventilation, PaO\u2082\/FiO\u2082 ratio, PaCO\u2082, esophageal pressure swings (\u0394Pes), central venous pressure swings (\u0394CVP), nasal pressure swings (\u0394Pnose), and diaphragmatic thickening fraction (TFdi). Composite scores like ROX and HACOR aid in predicting NRS outcomes.<\/p>\n<\/li>\n

  7. \n

    Gas Exchange and Carbon Dioxide Dynamics:<\/strong> Both oxygenation and ventilation status (e.g., SpO\u2082\/FiO\u2082 ratio and PaCO\u2082 levels) are critical in evaluating NRS efficacy, especially for guiding escalation decisions.<\/p>\n<\/li>\n

  8. \n

    Effort Monitoring and P-SILI Risk:<\/strong> Direct and surrogate markers of inspiratory effort (e.g., \u0394Pes, \u0394CVP, \u0394Pnose) are instrumental in detecting patients at risk of P-SILI or diaphragm injury due to overexertion during NRS.<\/p>\n<\/li>\n

  9. \n

    Decision-making for Escalation:<\/strong> Early improvements or deteriorations in clinical and physiological markers within the first 1\u20132 hours of NRS are key in determining whether to continue or escalate therapy.<\/p>\n<\/li>\n

  10. \n

    Need for Standardized Protocols and Future Tools:<\/strong> While current indices and tools provide guidance, the field requires further validation studies and development of non-invasive, practical bedside technologies for real-time effort and ventilation monitoring.<\/p>\n<\/li>\n<\/ol>\n

    \n
    \n
    \n
    \n
    Minimize image<\/div>\n
    Edit image<\/div>\n
    Delete image<\/div>\n<\/div>\n<\/div>\n

    \"\"<\/div>

    Integration of baseline characteristics and monitoring tools during non-invasive respiratory support. A simple algorithm is proposed based on baseline characteristics (i.e., oxygenation and clinical severity) to decide on the appropriateness of a trial of non-invasive respiratory support. Available tools to monitor response are also summarized. Duration of short trial and trial of intermediate duration depends on patients\u2019 individual response to therapy, authors suggest considering 1\u20132\u00a0h for a short trial and 3\u20136\u00a0h for a trial of intermediate duration. * intended to guide decisions in patients with acute hypoxemic respiratory failure of infectious etiology (e.g., Community acquired pneumonia) or ARDS. PaO2\/FiO2 ratio of arterial partial pressure of oxygen to fraction of inspired oxygen; IMV invasive mechanical ventilation; CPAP continuous positive airway pressure; NIV non-invasive ventilation; HFNO high flow nasal oxygen; Vt\/PBW ratio of tidal volume to predicted body weight; SPO2\/FiO2 ratio of oxygen saturation to fraction of inspire oxygen; PaCO2 arterial partial pressure of carbon dioxide; \u0394Pes esophageal pressure swing; \u0394Pnose swing in nasal pressure; \u0394CVP swing in central venous pressure; EIT electrical impedance tomography; CoV center of ventilation; GI index inhomogeneity index; TFdi thickening fraction of the diaphragm<\/figcaption><\/figure>\n
    \n
    \n
    <\/div>\n<\/div>\n

    Conclusion:<\/strong> Non-invasive respiratory support provides a valuable bridge in managing ARF without immediate intubation. However, it requires meticulous patient selection, close physiological monitoring, and timely recognition of failure to prevent adverse outcomes. Tailoring NRS through continuous evaluation of effort, gas exchange, and comfort can reduce the risks of P-SILI and delayed intubation. Future research should prioritize the standardization and validation of monitoring protocols and emerging tools to enhance patient-specific care.<\/p>\n

    \n
    \n
    \n
    \n
    Minimize image<\/div>\n
    Edit image<\/div>\n
    Delete image<\/div>\n<\/div>\n<\/div>\n

    \"\"<\/div>

    Esophageal catheter insertion during non-invasive respiratory support. Respiratory recordings during non-invasive ventilation through facemask. Airway pressure, auxiliary pressure, and transpulmonary pressure (difference between airway pressure and esophageal pressure) are displayed (top, medium, and bottom respectively). Vertical dotted lines indicate separation between the respiratory cycles. Of note, during high flow nasal oxygen, there is no airway pressure monitoring and identification of individual respiratory cycles, inspiration and expiration require observation of the patient. Panel A) shows the initial position of the catheter in the stomach (approximately 60\u00a0cm from the nostril). Gastric pressure (Pga) is recognized by the characteristic positive deflection in auxiliary pressure (Paux) during relaxed inspiration due to the caudal displacement of the diaphragm. Panel B) shows positioning of the catheter in the lower third of the esophagus (approximately 40\u00a0cm from the nostril). Paux becomes negative during inspiration and cardiac oscillations become more noticeable. Measurement of esophageal pressure swing (\u0394Pes) and lung stress (\u0394PL) are shown with vertical solid lines. Paw airway pressure; Paux auxiliary pressure; Pga gastric pressure; Pes esophageal pressure; PL transpulmonary pressure<\/figcaption><\/figure>\n
    \n

    ACCESS FULL ARTICLE HERE<\/a><\/p>\n<\/blockquote>\n

    \n
    \n
    \n
    \n
    Minimize image<\/div>\n
    Edit image<\/div>\n
    Delete image<\/div>\n<\/div>\n<\/div>\n

    \"\"<\/div>

    Monitoring patients with acute respiratory failure during non-invasive respiratory support to minimize harm and identify treatment failure<\/figcaption><\/figure>\n
    \n

    Watch the following video on “Non-invasive respiratory support” by ISICEM<\/a><\/p>\n